Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.700
-0.050 (-1.82%)
At close: Sep 25, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
After-hours: Sep 25, 2026, 7:40 PM EDT
Zentalis Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
106
Market Cap
255.61M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 67.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bicycle Therapeutics | 61.21M |
| Q32 Bio | 53.74M |
| Sutro Biopharma | 45.70M |
| AC Immune | 21.67M |
| Lineage Cell Therapeutics | 13.08M |
| Camp4 Therapeutics | 4.22M |
| Palisade Bio | 500.00K |
| Vicore Pharma Holding AB | 412.09K |
ZNTL News
- 12 days ago - Zentalis initiated with an Outperform at William Blair - TheFly
- 13 days ago - Zentalis Pharmaceuticals Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 19 days ago - Zentalis Pharmaceuticals Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 25 days ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 weeks ago - Zentalis announecs common stock offering, no amount given - TheFly
- 6 weeks ago - Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - GlobeNewsWire